The mainstay of therapy for thrombotic thrombocytopenic purpura (TTP) is urgent therapeutic plasma exchange (TPE), which removes autoantibodies and replenishes the ADAMTS13 enzyme. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.